aTyr Pharma LIFE Stock
aTyr Pharma Price Chart
aTyr Pharma LIFE Financial and Trading Overview
| aTyr Pharma stock price | 1.6 USD |
| Previous Close | 2.21 USD |
| Open | 2.2 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1000 |
| Day's Range | 2.18 - 2.24 USD |
| 52 Week Range | 1.56 - 4.28 USD |
| Volume | 242.18K USD |
| Avg. Volume | 656.9K USD |
| Market Cap | 119.98M USD |
| Beta (5Y Monthly) | 1.257746 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.71 USD |
LIFE Valuation Measures
| Enterprise Value | 19.71M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.188119 |
| PEG Ratio (5 yr expected) | -0.17 |
| Price/Sales (ttm) | 11.552559 |
| Price/Book (mrq) | 1.0728155 |
| Enterprise Value/Revenue | 1.897 |
| Enterprise Value/EBITDA | -0.423 |
Trading Information
aTyr Pharma Stock Price History
| Beta (5Y Monthly) | 1.257746 |
| 52-Week Change | -16.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.28 USD |
| 52 Week Low | 1.56 USD |
| 50-Day Moving Average | 2.18 USD |
| 200-Day Moving Average | 2.36 USD |
LIFE Share Statistics
| Avg. Volume (3 month) | 656.9K USD |
| Avg. Daily Volume (10-Days) | 305.5K USD |
| Shares Outstanding | 54.29M |
| Float | 43.88M |
| Short Ratio | 0.51 |
| % Held by Insiders | 10.03% |
| % Held by Institutions | 58.98% |
| Shares Short | 427.77K |
| Short % of Float | 1.19% |
| Short % of Shares Outstanding | 0.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -450.73% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.21% |
| Return on Equity (ttm) | -43.39% |
Income Statement
| Revenue (ttm) | 10.39M USD |
| Revenue Per Share (ttm) | 0.33 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -32422000 USD |
| EBITDA | -46582000 USD |
| Net Income Avi to Common (ttm) | -45136000 USD |
| Diluted EPS (ttm) | -1.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 114.39M USD |
| Total Cash Per Share (mrq) | 2.11 USD |
| Total Debt (mrq) | 14.29M USD |
| Total Debt/Equity (mrq) | 13.02 USD |
| Current Ratio (mrq) | 8.748 |
| Book Value Per Share (mrq) | 2.06 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -32357000 USD |
| Levered Free Cash Flow (ttm) | -20609124 USD |
Profile of aTyr Pharma
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3545 John Hopkins Court |
| ZIP | 92121 |
| Phone | 858 731 8389 |
| Website | https://www.atyrpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 65 |
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.
Q&A For aTyr Pharma Stock
What is a current LIFE stock price?
aTyr Pharma LIFE stock price today per share is 1.6 USD.
How to purchase aTyr Pharma stock?
You can buy LIFE shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for aTyr Pharma?
The stock symbol or ticker of aTyr Pharma is LIFE.
Which industry does the aTyr Pharma company belong to?
The aTyr Pharma industry is Biotechnology.
How many shares does aTyr Pharma have in circulation?
The max supply of aTyr Pharma shares is 73.89M.
What is aTyr Pharma Price to Earnings Ratio (PE Ratio)?
aTyr Pharma PE Ratio is now.
What was aTyr Pharma earnings per share over the trailing 12 months (TTM)?
aTyr Pharma EPS is -0.94 USD over the trailing 12 months.
Which sector does the aTyr Pharma company belong to?
The aTyr Pharma sector is Healthcare.
aTyr Pharma LIFE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}